TARS
#1836
Tarsus Pharmaceuticals, Inc. - Common Stock
59.3 1 USD
+0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+2.01%
Monthly Change
-4.46%
6 month change
-21.42%
Year Change
-10.22%
Previous Close
58.1 4
Open
59.3 1
Low
59.3 1
High
59.3 1
Volume
78
Financials
- Market Capitalization 2.55 B
- Employee 370
- Founded 2016
- CEO N/A
- Website www.tarsusrx.com
- Headquarter Delaware, United States
- FIGI BBG00RB9BNQ7
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-51.5
Price to sales ratio
7.58
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1827 |  IMNM Immunome, Inc. - Common Stock | 22.80 USD | -2.36% | -5.00% | +22.38% | +166.36% | 2.58 B USD | ||
| 1829 |  KOD Kodiak Sciences Inc - Common Stock | 41.10 USD | -0.51% | +9.34% | +17.80% | +675.47% | 2.57 B USD | ||
| 1845 |  BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.91 USD | -5.17% | -4.16% | +13.13% | +10.11% | 2.52 B USD | ||
| 1865 |  VCEL Vericel Corporation - Common Stock | 47.49 USD | +1.04% | +0.87% | +25.40% | +30.65% | 2.43 B USD |
Frequently asked questions about Tarsus Pharmaceuticals, Inc. - Common Stock
What is the Tarsus Pharmaceuticals, Inc. - Common Stock stock price today?
The current price of Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) is 59.31. Over the past 24 hours, the stock has changed by +2.01%. Follow the TARS chart for real-time price dynamics.
What is the stock ticker of Tarsus Pharmaceuticals, Inc. - Common Stock?
Tarsus Pharmaceuticals, Inc. - Common Stock trades under the ticker TARS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Tarsus Pharmaceuticals, Inc. - Common Stock stock going up?
TARS has changed by -13.26% over the last week, -4.46% over the last month, and -10.22% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Tarsus Pharmaceuticals, Inc. - Common Stock net income for the last quarter?
Tarsus Pharmaceuticals, Inc. - Common Stock reported net income of -6.97 M for the last quarter. The previous quarter showed -8.37 M, which means net income changed by +16.79%.
How many employees does Tarsus Pharmaceuticals, Inc. - Common Stock have?
As of the latest available data, Tarsus Pharmaceuticals, Inc. - Common Stock has 370 employees. Workforce size can provide additional context about the company's scale and operations.
What is Tarsus Pharmaceuticals, Inc. - Common Stock EBITDA?
Tarsus Pharmaceuticals, Inc. - Common Stock EBITDA is -6.38 M, and its EBITDA margin is -3.93%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Tarsus Pharmaceuticals, Inc. - Common Stock stock?
You can buy Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Tarsus Pharmaceuticals, Inc. - Common Stock stock?
Investing in Tarsus Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TARS chart and related analysis on metatrader.com as part of your research.